Effectiveness of 1-year treatment with long-acting formulation of aripiprazole, haloperidol, or paliperidone in patients with schizophrenia: retrospective study in a real-world clinical setting

BACKGROUND: Schizophrenia is a chronic mental illness that requires lifelong antipsychotic treatment. Therapy discontinuation, often due to poor adherence, increases the risk of relapses after both first and subsequent psychotic episodes. Long-acting injectable (LAI) antipsychotic drugs (APDs) have...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Lorenzo, Rosaria, Ferri, Paola, Cameli, Michela, Rovesti, Sergio, Piemonte, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328290/
https://www.ncbi.nlm.nih.gov/pubmed/30662264
http://dx.doi.org/10.2147/NDT.S189245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328290/
https://www.ncbi.nlm.nih.gov/pubmed/30662264
http://dx.doi.org/10.2147/NDT.S189245

Ejemplares similares